← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
HCA grew revenue and cash flow, then spent more than free cash flow on buybacks while leverage stayed high.
The read at a glance✓ Audited against SEC data
- Growth — +7.1% revenue to $75.60BOK
- Profitability — Net income +17.8% to $6.78BOK
- Cash quality — Free cash flow +36.4% to $7.69BOK
- Margins — Net margin +81 bps; FCF margin +218 bpsOK
- Capital — Buybacks +66.6% to $10.07B; debt +2.9%Watch
- Insiders — 0 open-market buys / 7 sellsWatch
Business
HCA Healthcare is a large U.S. health care services company. At December 31, 2025, it operated 190 hospitals, 121 freestanding ambulatory surgery centers, and 31 freestanding endoscopy centers across 19 states and England.
Where the revenue comes from
Fiscal 2025, as HCA Healthcare, Inc. reports it. History and quarterly detail are in the app.
- American Group$26.4B
- Atlantic Group$24.7B
- National Group$21.3B
- Corporate And Other$3.2B
Leadership changes
From HCA Healthcare, Inc.'s own filings, the day they're filed.
- Michael Cuffe · Chief Clinical Officer · departureeff. 2026-08-31
- Robert J. Dennis · Directors · departureeff. 2026-02-20
- John W. Chidsey III · appointmenteff. 2025-07-15
Latest filings
- 8-K · Company announcement2026-07-29
- 10-Q · Quarterly report2026-07-28
- 8-K · Company announcement2026-07-24
- 8-K · Company announcement2026-07-14
- 8-K · Company announcement2026-06-18
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about HCA Healthcare, Inc., every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.